Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(R)-ND-336 is a highly potent and selective MMP-9 inhibitor, displaying a K i value of 19 nM. It also exhibits inhibitory activity against MMP-2 (K i = 127 nM) and MMP-14 (K i =119 nM). With its significant potential, (R)-ND-336 is being investigated in the field of diabetic foot ulcers (DFUs) research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,140.00 | |
50 mg | 6-8 weeks | $ 2,785.00 | |
100 mg | 6-8 weeks | $ 3,520.00 |
Description | (R)-ND-336 is a highly potent and selective MMP-9 inhibitor, displaying a K i value of 19 nM. It also exhibits inhibitory activity against MMP-2 (K i = 127 nM) and MMP-14 (K i =119 nM). With its significant potential, (R)-ND-336 is being investigated in the field of diabetic foot ulcers (DFUs) research [1]. |
In vitro | (R)-ND-336 exhibits minimal inhibition of other MMPs, with an inhibition constant (K i ) greater than 100 μM. It possesses a prolonged residence time of 300 minutes, indicative of the duration it remains bound to MMP-9. Moreover, (R)-ND-336 demonstrates a promising IC50 value of 143 μM, resulting in a therapeutic index ratio of 7530. This highlights its significant selectivity for MMP-9 over other MMPs without being cytotoxic [1]. |
In vivo | (R)-ND-336, applied topically at 50 μg per wound daily over a 14-day period, significantly enhances wound healing, as evidenced by accelerated healing rates. Pharmacokinetic measurements reveal that (R)-ND-336 achieves an area under the curve (AUC) of 1.3 μM·min following topical administration and 35 μM·min after intravenous administration, with a resultant AUC ratio (topical to intravenous) of 3.7%. This indicates that topical application results in minimal systemic absorption in the db/db mouse model. Specifically, the study utilized female db/db mice, aged 8 weeks and weighing approximately 40g, to assess the compound's efficacy. The findings demonstrate not only accelerated wound healing but also the complete inhibition of MMP-9 enzyme activity, thus proving (R)-ND-336's potential therapeutic benefits. |
Molecular Weight | 371.89 |
Formula | C16H18ClNO3S2 |
CAS No. | 2252493-33-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(R)-ND-336 2252493-33-5 inhibitor inhibit